Triple-Negative Breast Cancer (TNBC) Not Yet Recruiting Phase 2 Trials for Vinorelbine (DB00361)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03932526Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast CancerTreatment